Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Supernus Pharmaceuticals (SUPN) has a market cap of $1.76 billion USD. According to our data, Supernus Pharmaceuticals is ranked No.4184 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $1.76 B |
-12.06%
|
| Dec 31, 2024 | $2.00 B |
24.95%
|
| Dec 29, 2023 | $1.60 B |
-18.87%
|
| Dec 30, 2022 | $1.97 B |
22.33%
|
| Dec 31, 2021 | $1.61 B |
15.90%
|
| Dec 31, 2020 | $1.39 B |
6.07%
|
| Dec 31, 2019 | $1.31 B |
-28.60%
|
| Dec 31, 2018 | $1.83 B |
-16.64%
|
| Dec 29, 2017 | $2.20 B |
57.82%
|
| Dec 30, 2016 | $1.39 B |
87.87%
|
| Dec 31, 2015 | $0.74 B |
61.93%
|
| Dec 31, 2014 | $0.46 B |
10.08%
|
| Dec 31, 2013 | $0.42 B |
5.16%
|
| Dec 31, 2012 | $0.40 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Jazz Pharmaceuticals
JAZZ
|
$6.25 B |
0.000 M
|
Ireland
|
 Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
Israel
|
 Amneal Pharmaceuticals
AMRX
|
$3.34 B |
1.091 B
|
USA
|
 Perrigo
PRGO
|
$3.42 B |
-0.000 M
|
Ireland
|
 Bausch Health
BHC
|
$1.67 B |
-0.000 M
|
Canada
|
 Alkermes
ALKS
|
$4.61 B |
-0.000 M
|
Ireland
|
 Ironwood Pharmaceuticals
IRWD
|
$0.12 B |
-0.000 M
|
USA
|
 Pacira Biosciences
PCRX
|
$1.15 B |
-0.000 M
|
USA
|
 Collegium Pharmaceutical
COLL
|
$0.87 B |
0.000 M
|
USA
|
 Assertio Therapeutics
ASRT
|
$60.28 M |
-0.000 M
|
USA
|
 Corcept Therapeutics
CORT
|
$7.34 B |
0.000 M
|
USA
|
| Market Cap | = | SUPN Stock Price | * | SUPN Shares Outstanding |
| = | $31.46 | * | 55.81 M | |
| = | $1.76 B |